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ABSTRACT
Objective: To investigate microorganisms causing bacteremia in Jordanian children and to assess their sensitivity to 
various groups of antimicrobials.
Methods: A retrospective study was conducted on positive blood cultures taken from 378 children aged below 15 year, who 
sought medical attention at Princess Rahmah Hospital between January and December/2008.
Results: Out of 4475 tested blood samples, 378 isolates were recovered from blood cultures. The male to female isolate ratio 
was (1.26:1.0). The most frequent pathogen found was Staphylococcus aureus (86.2%), followed by Klebsiella spp. (9%), 
Escherichia coli (1.9%), Streptococcus spp. (1.9%), Pseudomonas spp. (0.8%), and Acinetobacter sp. was found in only 
one culture (0.3%). The susceptibility rate of S. aureus was recorded the highest (99.6%) for vancomycin, and the lowest 
susceptibility rate (3.2%) was recorded for aztreonam. 
Conclusions: Staphylococcus aureus was the main isolate in bacteremic children, with all isolates demonstrating susceptibility 
to vancomycin.  Overall, aztreonam resistance was near 97%, and this rate was not affected by sex and blood isolate type. 
This information should be considered when empirical therapy is recommended or prescribed for children with bacteremia.
Keywords: Bacteremia, Child Fever, Antimicrobials, Drug resistance.
INTRODUCTION
Bacteremia is a common cause of morbidity and 
mortality in children (1) worldwide (2–5). Therefore, 
bacteremia  continues  to  be  a  serious  problem  that 
needs  immediate  attention  and  treatment.  For  an 
accurate  diagnosis  and  an  appropriate  choice  of 
antimicrobials,  blood  culture,  which  usually  takes 
a  few  days,  is  required.  The  empirical  choice  of 
antimicrobials  for  the  treatment  of  bacteremia  is 
guided by an awareness of previous culture reports. 
Up-to-date information on the local etiologic patterns 
and  antimicrobial  sensitivities  is  also  important. 
Different factors contribute to the prognosis of the 
infection  such  as  the  type  of  microorganism,  age, 
underlying  disease  and  microorganism  entry  (6). 
However,  bloodstream  infections  in  hospitalized 
patients are usually attributable to the use of central 
venous lines.
In a prospective five-year study on 344 clinically 
significant episodes of pediatric septicemia the most 
common  organisms  found  were  Salmonella  spp. 
(15.0%) followed by methicillin-resistant S. aureus. 
They reported that Haemophilus influenzae accounted 
for  2.0%  of  all  episodes  (7).  Another  study  also 
reported that of 408 bacterial strains, Salmonella spp. 
were the most commonly isolated (23%), followed 
by S. aureus and Acinetobacter-Moraxella (8). The 
most frequent etiologic agents of bacteraemia cases 
include  Staphylococcus  spp.,  Streptococcus  spp., 
Enterobacter  spp.,  Escherichia  coli,  Klebsiella 
pneumoniae and Pseudomonas spp. (1, 6). However, 
etiologies of bacteremia and sensitivities have been 
changing over the past years (9, 10).
The  rapid  emergence  of  multidrug  resistant 
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bacteremia in developing countries is a new potential 
threat to the survival of newborn babies, who are 
in  a  poor  health  condition.  Therefore,  this  study 
was  conducted  to  assess  the  causative  organisms 
and susceptibility pattern of bacteremia pathogens 
isolated from children in of 2008 (from Jan to Dec. 
2008) at Princess Rahmah Hospital in Irbid, Jordan. 
The importance of this study is to aid clinicians to 
facilitate the empiric treatment and management of 
children  with  symptoms  of  bacteremia.  Moreover, 
the  data  would  also  help  authorities  to  formulate 
antibacterial prescription policies. 
MATERIALS AND METHODS
This retrospective study was conducted on 4475 
blood specimens obtained from sick children (< 15 
years  of  age)  who  attended  the  Princess  Rahmah 
Hospital  as  outpatients  or  inpatients  and  were 
diagnosed  with  bacteremia  between  January  and 
December, 2008. A total of 378 isolates were recovered 
from blood cultures, and the repeated positive blood 
cultures were not considered.
The  microorganisms  and  antibacterial 
susceptibility  data  were  obtained  from  the  clinical 
microbiology  laboratory  records  which  filled  in  a 
prepared  data  sheet.  Sampling  process,  culturing, 
bacterial identification and susceptibility testing for 
antimicrobials were as follows:  
Blood specimens were collected in a blood culture 
bottle  that  contained  50  ml  of  tryptose  phosphate 
broth  and  0.02%  polyanethol  sulfonate  (liquid). 
Following  standard  aseptic  procedure,  culture  was 
incubated at 37ºC for 24 hours prior to the isolation 
and identification of the bacteria.
Based  on  the  Gram-staining  characteristics  of 
the bacteria growth in the blood culture bottle was 
subcultured  onto  MacConkey  agar,  Salmonella-
Shigella  agar,  and  Nutrient  agar  and/or  blood  agar 
plates.  Bacteria  isolated  from  colonies  were  further 
characterized  by  special  biochemical  and  serological 
methods (11).
All isolates were tested for their susceptibilities to 
at least 8 out of 15 antimicrobials using antimicrobial 
diffusion discs (12). Bacterial sensitivity was tested for 
the following antimicrobials: Amikacin, Amoxicillin-
Clavulanic  acid,  Ampicillin,  Aztreonam,  Cefaclor, 
Cefotaxime,  Ceftazidime,  Ceftriaxone,  Cephlexin, 
Ciprofloxacin,  Gentamicin,  Imipenem,  Pipracillin, 
Tobramycin and Vancomycin. 
Data  were  analyzed  statistically  using  SPSS 
(version  15  for Windows)  program  calculating  the 
frequency and cross tabulations.  
This protocol was approved by the Ethics Committee 
of the Ministry of Health in Jordan (MOH,  REC, 08, 
0057).
RESULTS
In  a  12-month  duration  (January  to  December 
2008), a total of 378  out of 4475 blood samples of 
children  below  15  years  of  age  (55.8%  male  and 
44.2% female) that gave a  positive blood culture 
reaction  were  studied.  Results  showed  that  the 
majority of pathogens isolated were Staphylococcus 
aureus (86.2%), followed by Klebsiella spp. (9%), 
Escherichia coli (1.9%), Streptococcus spp. (1.9%), 
Pseudomonas  spp  (0.8%)  and  Acinetobacter  spp. 
(0.3%)  (Table  1).  The  antimicrobial  susceptibility 
of bacteremia isolates for 15 selected antimicrobial 
agents used in this study are summarized in Table 2.
The  highest  susceptibility  rate  of  S.  aureus 
was to vancomycin (99.6%),   whereas the lowest 
susceptibility  rate  was  to  aztreonam  (3.2%).  The 
highest  susceptibility  rate  of  other  isolates  i.e. 
Klebsiella  spp.  were  to  ciprofloxacin  91.3%,  E. 
coli  and  Pseudomonas  spp  demonstrated  100% 
susceptibility   to amikacin. Streptococcus spp. and 
Acinetobacter spp demonstrated 100% susceptibility 
to  both  aztreonam  and  ciprofloxacin.  Whereas, 
the lowest susceptibility rate for all other isolates, 
Klebsiella spp. E. coli, Pseudomonas, Streptococcus 
spp. and Acinetobacter spp was to ampicillin (0%). 
However,  vancomycin  was  detected  to  give  the 
highest  susceptibility  rate  (91.5%)  to  a  variety  of 
bacteremia isolates, aztreonam exhibited the lowest 
susceptibility rate of 5.8% (Table 3).
(%)  Total
 Sex
 Bacteria
F M
86.2 326 150 176 S. aurous 1
9 34 12 22 Klebsiella spp. 2
1.9 7 2 5 E. coli 3
19 7 2 5 Streptococcus spp. 4
0.8 3 1 2 P. aeruginosa 5
0.3 1 0 1 Acinetobacter spp. 6
100.0 378 167 211  Total
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n = Number of total isolates
No = Number of tested isolates
 S% = Percentage of Sensitive isolates
Acinetobacter spp.  Pseudomonas spp. Streptococcus spp. E. coli Klebsiella spp. S. aurous
 Drug n = 1 n = 3 n = 7 n = 7 n = 34 n = 326
S%  No S% No S% No S% No S% No S% No
0 0 0 1 0 0 0 0 20 5 76.4 34 Amoxicillin-Clavulanic
 acid
0 1 100.0 3 28.5 7 100.0 7 38.7 31 81.8 319 Amikacin
0 1 0 1 0 2 0 2 0 13 32 106 Ampicillin
100.0 1 33.3 3 100.0 5 71.4 7 16.6 30 3.2 311 Aztreonam
100.0 1 33.3 3 16.6 6 85.7 7 41.3 29 25 276 Ceftazidime
0 0 0 0 0 0 100.0 1 0 2 85.7 7 Cefaclor
0 0 0 0 0 0 100.0 1 33.3 9 13.2 83 Cephlexin
100.0 1 100.0 2 100.0 5 85.7 7 91.3 23 79.2 262 Ciprofloxacin
0 1 0 3 83.3 6 71.4 7 16.1 31 44.9 289 Ceftriaxone
0 0 66.6 3 85.7 7 66.6 6 12.5 32 69.4 262 Cefotaxime
0 1 66.6 3 42.8 7 42.8 7 193 31 60.6 282 Gentamicin
100.0 1 0 3 0 3 42.8 7 9.0 22 4.7 272 Imipenem
0 1 66.6 3 100.0 5 57.1 7 13.3 30 52.1 303 Pipracillin
0 1 66.6 3 57.1 7 85.7 7 20.0 30 83.5 317 Tobramycin
0 0 0 0 83.3 6 14.2 7 20 24 99.6 295 Vancomycin
Table 2. Susceptibility rates of blood bacterial isolates to antimicrobial agents.
Table 3. Susceptibility rate (%) of different blood bacterial isolates 
to antimicrobial agents.
Bacteria
Drug
% Susceptible Number of isolates
91.5 304 332 Vancomycin
81.0 243 300 Ciprofloxacin
77.5 287 370 Amikacin
77.5 283 365 Tobramycin
70.0 7 10 Cefaclor
67.5 27 40 Amoxicillin-Clavulanic 
acid
63.8 198 310 Cefotaxime
55.8 185 331 Gentamicin
49.5 173 349 Pipracillin
37.1 160 431 Ceftriaxone
28.0 35 125 Ampicillin
27.6 89 322 Ceftazidime
16.1 15 93 Cephlexin
7.5 27 358 Imipenem
5.8 21 357 Aztreonam
DISCUSSION
This  current  study  provides  information 
regarding the main etiological agent S. aureus that 
causes  bacteremia  in  children  of  both  inpatients 
and  outpatient  and  its  antimicrobial  susceptibility 
patterns. These results are in agreement with other 
studies that reported S. aureus as the most common 
bacteria isolated from blood of children (13-15).
An increase in the occurrence of Staphylococcal 
bacteremia is likely to be related to the increased use 
of intravascular catheters in medical care centers and 
puncture wounds (16, 17). The second most common 
organism  causing  bacteremia  in  this  study  was 
klebsiella spp. (9%). Similar results were reported by 
Rahman et al 2002 (14). However Klebsiella was the 
most common cause of neonatal sepsis in Karachi, 
Pakistan (18). However, in another studies conducted 
elsewhere,  Pseudomonas aeruginosa was the most 
common organism (38.3%) followed by Klebsiella 
(30.4%) and E coli (15.6%) (19). 
In this study, the occurrence of E.coli, Streptococcus 
spp, Pseudomonas spp and Acinetobacter spp were 
1.9%,  1.9%  0.8%  and  0.3%  respectively.  Higher 
occurrence of these blood isolates was reported in 
different literature (13, 19, 20). 25 BACTEREMIA IN CHILDREN
The  most  effective  antimicrobial  agent  against 
Staphylococcus  aureus  demonstrated  in  this  study 
was  vancomycin  (99.6%),  followed  by  cefaclor 
(85.7%), tobramycin (83.5%), ciprofloxacin (79.3%), 
amoxicillin-cavulanate  (76.4%)  and  gentamicin 
(60.6%).  Whereas  low  susceptibility  rates  were 
observed with ceftazidime (25%), cephlexin (13.2%), 
imipenem  (4.7%)  and  aztreonam  (3.2%).  Similar 
results for vancomycin, ciprofloxacin and amoxicillin-
cavulanate  were  reported  in  Jordan  (21)  and 
elsewhere (22).  However, same authors reported high 
susceptibility rates of S. aureus, reaching 85-100% to 
both ceftazidime and gentamicin respectively. 
In  this  study,  Staphylococcus  aureus  showed 
resistant rate to ampicillin accounted for 67% which 
was lower than documented resistance rate of 85% 
conducted elsewhere 23).
However, the highest resistance rate (100%) to 
ampicillin observed in this study was for Klebsiella, 
E.coli,  Streptococcus  spp,  Pseudomonas  spp  and 
Acinetobacter spp. Similarly low susceptibility rate 
(0%)  of  Acinetobacter  spp  to  ampicillin  has  been 
reported in the literature (22). 
in  this  study,  the  susceptibility  rate  of 
Staphylococcus  aureus  to  cefaclor,  amikacin, 
gentamicin  and  ceftriaxone  was  85.7%,  81.8%, 
60.6% and 44.9% respectively, which was lower than 
that reported by Shwe et al. 2002 (24). 
The increasing rates of resistance in Staphylococcus 
aureus may be due to changes in the pathogen over 
the  past  years  (10,  24).  Ciprofloxacin  showed  to 
be the most effective drug for Klebsiella spp. with 
susceptibility rate of 91.3% which was higher than 
that reported previously in Jordan (25). However, the 
higher susceptibility rate of 100% to ciprofloxacin 
was reported in Tanzania (22).
At the same time, all blood isolates from selected 
children of this study showed highest susceptibility 
rate to vancomycin (91.5%) followed by ciprofloxacin 
(81.0%), amikacin (77.5%),   tobramycin (77.5%),     
cefaclor  (70.0%),  amoxicillin-clavolanic  acid 
(67.5%), cefotaxime (63.8%) and gentamicin (55.8%). 
Comparatively lower susceptibility rate to pipracillin 
(49.5%),  ceftriaxone  (37.1%),  ampicillin  (28%), 
ceftazidime (27.6%), cephlexin (16.1%), imipenem 
(7.5%)  and  aztreonam  (5.8%)  was  demonestrated. 
These  results  are  correspondent  with  the  reported 
data (22, 26). 
To  conclude,  the  finding  of  this  study  showed 
that  bacteremia  in  children  is  mainly  caused  by 
Staphylococcus  aureus  organisms,  which  develop 
resistance  to  commonly  used  antimicrobials. 
This  emergence  of  multiple  drug  resistance  calls 
for  continuous  monitoring  and  reviewing  of 
antimicrobial policy in hospitals and the country at 
large. Therefore, this study is important for clinicians 
in order to facilitate the empiric treatment of children 
with  symptoms  of  bacteremia.  Moreover,  the  data 
would  also  help  authorities  to formulate antimicrobial 
prescription policies.
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